This article explains how labs, renewals, pharmacy fulfillment, and communication with your clinician work when you’re on the Oral TRT (Native Testosterone) Protocol.
Labs and Monitoring
Oral TRT influences hormone levels over time. Because each person responds differently, labs and regular clinical check-ins are essential to ensure the protocol remains safe and effective.
Before Starting
Your clinician reviews your medical history and baseline labs before prescribing Oral TRT. These labs help evaluate your hormone levels and overall health to determine eligibility and safety.
Follow-Up Labs
Follow-up labs may be required during treatment. These evaluations help your clinician:
Understand how your body is responding
Review hormone changes
Monitor relevant health markers
Determine whether any adjustments are appropriate
You’ll be notified through your account when follow-up labs are needed.
Renewals and Refills
Renewals depend on:
Your lab results
Your reported symptoms
Your health status
Your clinician’s medical judgment
A refill may not be approved if required labs or check-ins are missing. This ensures proper oversight and safe use of hormone therapy.
Pharmacy and Shipping
After your clinician approves a refill:
The prescription is sent to a partner pharmacy
The medication is prepared for shipment
Shipping times vary based on location and carrier
Most orders ship from a pharmacy hub, and tracking information is typically provided once the order is fulfilled. If you experience a delay or issue with your shipment, Support can help resolve it.
State Availability
The Oral TRT Protocol is available in states where Maximus clinicians are licensed to provide care. If you change your residence or shipping address, availability may change. Your account will always display whether this protocol is currently offered in your state.
Messaging Your Clinician
You can reach your clinician through your patient portal for questions about:
Symptoms
Side effects
Lab results
General concerns about treatment
Urgent or severe symptoms should be addressed through emergency medical care rather than portal messaging.
